**What is already known**

The incidence of sepsis and mortality have increased worldwide. The epidemiological characteristics of sepsis in Korea are yet unknown.

**What is new in the current study**

Although the incidence of sepsis in Korea has increased, the mortality rate has remained steady.

INTRODUCTION
============

Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. It has very high morbidity and mortality rates and is a public health problem worldwide \[[@b1-ceem-18-007],[@b2-ceem-18-007]\].

To improve its outcomes, it is critical to provide optimal management in every aspect of care including initial screening, hemodynamic optimization, antibiotic treatment, and source control \[[@b3-ceem-18-007]\]. This requires rapid but coordinated approaches from multiple disciplines including the general public, emergency medical service, and hospitals with the support of proactive governmental policies. In this process, detailed national epidemiologic information about sepsis can play a critical role. However, no nationwide population-based study has been conducted in Korea compared to many other developed countries where such epidemiological information has been used to support healthcare policy making \[[@b4-ceem-18-007]-[@b20-ceem-18-007]\].

We conducted a longitudinal, population-based epidemiological study of sepsis in Korea using a nationally representative cohort database. The primary objective of the study was to estimate the incidence, mortality and cost of sepsis in Korea. The secondary objective was to identify risk factors for death due to sepsis in the Korean population.

METHODS
=======

This study was approved by IRB of Seoul National Bundang Hospital, institutional review board determined the study was exempt (SNUBH IRB X-1502-288-903).

Data source
-----------

The data source was the National Health Insurance Service-National Sample Cohort, a population-based cohort established by the Korean National Health Insurance Service \[[@b21-ceem-18-007]\]. It contains claim information of over one million individuals (2.2%) who were randomly sampled from almost the entire Korean population using stratification. It provides information about diagnoses, prescriptions, procedures, and related costs as well as basic demographic information such as age, sex, and socioeconomic status. Diagnoses are coded using the Korean Classification of Diseases, sixth revision which is based on the tenth revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10). It also contains information about disability and death based on the disability registration data and the officially-issued death certificates, respectively. We used its most recent release which contains claim data from 2005 to 2012. The detailed description of the cohort can be found in a previous paper \[[@b21-ceem-18-007]\].

Case selection and the variables analyzed
-----------------------------------------

Claim records of adult patients (aged ≥15 years) admitted to hospitals were used for case definition. We identified sepsis using the following procedures ([Fig. 1](#f1-ceem-18-007){ref-type="fig"}). The entire claim information for an admission is often separated into multiple records covering different time segments of admission. Therefore, we first linked successive claim records corresponding to each admission. Then a case of sepsis was defined as an admission with at least one occurrence of claim record fulfilling all the following conditions: 1) bacterial or fungal infection or the conditions that are often complicated by such infections (e.g., surgical abdomen) as indicated by the primary or first secondary diagnostic codes (please refer to the [Appendix 1](#app1-ceem-18-007){ref-type="app"} for a detailed list of ICD-10 codes), 2) prescription of intravenous antibiotics (parenteral antibiotics with Anatomical Therapeutic Chemical Classification System code J01), and 3) presence of organ dysfunction involving at least one system (please refer to the [Appendix 1](#app1-ceem-18-007){ref-type="app"} for a detailed list of ICD-10 codes). Septic shock was defined as the inclusion of R57.2 (septic shock) in the diagnostic codes or the use of intravenous vasopressors such as dopamine, dobutamine, norepinephrine, vasopressin, and epinephrine.

Comorbidities for each of the cases were defined using the first claim record fulfilling the sepsis criteria and the admission claim records within three years prior to the first sepsis record using the Charlson/Deyo method \[[@b22-ceem-18-007]-[@b24-ceem-18-007]\]. Ancillary variables including household income level, emergency room (ER) presentation, type of admitting department, and hospital capacity measured by the number of beds were also included in the analyses. Length of stay, overall cost, intensive care unit (ICU) admission and 6-month mortality were included as outcome measures. We excluded the claim records beginning more than a year after the event when calculating the length of stay and cost because we thought prolonged admission more than a year after the index event would hardly be due to the index event. The detailed coding schemes are available in the [Appendix 1](#app1-ceem-18-007){ref-type="app"}.

Statistical analysis
--------------------

Both crude and standardized annual incidence of sepsis in the adult population (aged ≥15 years) were calculated. The standardized annual incidence based on the sex-age distribution of the 2010 Korean census was estimated by direct standardization \[[@b25-ceem-18-007]\]. Similarly, both crude and standardized 6-month mortality were calculated using the direct standardization method based on the sex-age distribution sepsis cases for the year 2010. The average (both mean and median) cost per case and the total national cost for each year were estimated in Korean won (KRW). The standardized annual average cost based on the sex-age distribution of sepsis cases from 2010 was also calculated. The trend analyses for dichotomous events were conducted using logistic regression, and those for continuous variables were conducted using linear regression.

Survival curves for the sepsis patients during the first six months were plotted using the Kaplan-Meier method and comparisons between groups were made using the log-rank test. To identify independent risk factors for mortality, we performed multivariable logistic regression analyses using two different model-building schemes. The first involved comprehensive modeling using all available variables and data. The second involved parsimonious modeling with a variable selection scheme based on Bayesian information criterion using 80% of randomly selected cases (training set) which was later tested using the remaining 20% of cases (test set). The results of the logistic regression were presented as odds ratios and their 95% confidence intervals (CIs). All data handling and statistical analyses were performed using R ver. 3.3.2 (R Foundation for Statistical Computing, Vienna, Austria).

RESULTS
=======

From 2005 to 2012, a total of 22,882 sepsis cases were identified from the cohort ([Table 1](#t1-ceem-18-007){ref-type="table"}). More than half of the patients (14,028; 61.3%) were older than 65 years and had at least one comorbidity (11,615; 50.8%). Over half of the cases initially presented to the ER (13,128; 57.4%) and over two-thirds were treated in the medical department (16,212; 70.9%). Their income levels showed a polarized pattern with almost half of the cases (11,836; 51.7%) in the lowest and highest income classes. Majority of the cases (17,619; 77.0%) were treated in larger hospitals with capacities of 300 beds or higher. The most common type of organ dysfunction was respiratory failure (11,854; 51.8%) followed by hemodynamic failure (10,792; 47.2%) and the most common site of infection was the respiratory system (12,255; 53.6%). Almost half of the cases were complicated by septic shock (10,570; 46.2%) and almost one-third of the cases involved ICU admission (7,131; 31.2%). The median length of stay was 13 (interquartile range, 7 to 26) days and the median cost was 276 (interquartile range, 144.2 to 621.8)×10,000 KRW and the 6-month mortality rate was 29.5%.

[Fig. 2](#f2-ceem-18-007){ref-type="fig"} shows the eight-year trend of sepsis incidence and mortality. There was a significant increase in crude incidence rate of sepsis from 265.7 (254.7 to 277.1) per 100,000 person-years in 2005 to 453.1 (439.0 to 467.5) per 100,000 person-years in 2012 (P-trend \<0.001). After standardization for both age and sex, the increase was less remarkable but still significant with 287.7 (275.8 to 300.1) in 2005 to 395.1 (382.7 to 407.8) in 2012 (P-trend \<0.001). The increase was more remarkable in the elderly population and the patients with significant comorbidity burdens. The crude mortality rate also gradually increased from 26.5% (24.4% to 28.8%) to 30.1% (28.4% to 31.9%) during the period (P-trend \<0.001). However, the trend was not significant after sex-age standardization (from 29.3% \[95% CI, 26.9% to 31.9%\] to 30.5 \[95% CI, 28.5% to 32.6%\]; P-trend=0.883). The crude mortality rate among patients with septic shock also gradually increased from 32.2% (28.8% to 35.9%) to 38.5% (35.6% to 41.5%) during the period (P-trend \<0.001, [Supplementary Fig.1](#SD1-ceem-18-007){ref-type="supplementary-material"}). However, the trend was not significant after sex-age standardization (from 36.8% \[95% CI, 32.8% to 41.8%\] to 36.9 \[95% CI, 34.1% to 39.9%\]; P-trend 0.564).

The standardized average cost per case increased by 75.5% from 422.5 (95% CI, 396.9 to 448.1)×10,000 KRW in 2005 to 741.7 (95% CI, 701.5 to 781.9)×10,000 KRW in 2012 (P-trend \<0.001) ([Fig. 3](#f3-ceem-18-007){ref-type="fig"}). The estimated total national expenditure on sepsis was tripled (311.8%) during the same period with the estimated total amount of expenditure at 13,226.5×100,000,000 KRW in 2012 (P-trend \<0.001).

[Fig. 4](#f4-ceem-18-007){ref-type="fig"} shows the differential survival probabilities by age, comorbidity burden, organ dysfunction and site of infection. Older age, higher comorbidity burden, multiple organ dysfunction and primary respiratory infection were associated with higher mortality rates through the first 6 months (P\<0.001 for all). To identify independent risk factors for 6-month mortality, we performed multivariable logistic regression using two different model-building schemes. The first, using all predictors and cases, showed that older age, higher comorbidity burden, ER presentation, admission to the medical department, multiple organ dysfunction, central nervous system or unspecified site of infection (vs. respiratory system), and the development of septic shock were independently associated with increased mortality ([Table 2](#t2-ceem-18-007){ref-type="table"}). In contrast, female sex; higher income level; larger hospital capacity; and gastrointestinal, genitourinary, musculoskeletal, skin and soft tissue and device-related infections were associated with lower mortality. The second model was developed using 80% of the data (training set) using Bayesian information criterion for variable selection showed similar results, with patient age, sex, comorbidity level, admitting department, hospital capacity, organ dysfunction, site of infection, and the development of septic shock identified as independent predictors ([Table 3](#t3-ceem-18-007){ref-type="table"} and [Fig. 5](#f5-ceem-18-007){ref-type="fig"}). Its performance in predicting the 6-month mortality was tested in the remaining 20% of data (test set) which yielded an area under the receiver operating characteristic curve of 0.840 (95% CI, 0.829 to 0.852) ([Fig. 6](#f6-ceem-18-007){ref-type="fig"}).

DISCUSSION
==========

This study is the first longitudinal, population-based study of sepsis in Korea. We found that sepsis is a relatively common condition with very high mortality in Korea as in other countries. Its overall incidence was increasing and the increase was most prominent in the old age and high comorbidity populations. This rapid increase among old and debilitated sepsis patients was accompanied by the overall increase in mortality. The increase in incidence rate and the cost per case were accompanied by more than a triple increase in national expenditure on sepsis. Considering that population aging is still an ongoing process in Korea, we believe these trends will continue for a while \[[@b26-ceem-18-007]\].

We found several interesting but worrisome risk factors for mortality from sepsis. The association between lower family income level and higher mortality can be the sign of disparities in the quality of critical care according to income levels. Although there was universal healthcare coverage by the National Health Insurance Service in Korea throughout the study period, there could be significant disparities in care as shown in previous studies of cardiovascular and cancer-related mortalities in the Korean population \[[@b27-ceem-18-007]-[@b29-ceem-18-007]\].

Another risk factor was smaller hospital capacity. It is possible that smaller hospitals have narrower ranges of available diagnostic tests and limited capacity for prompt source control which requires duty surgeons or interventional radiologists. It is also possible that the availability of critical care specialists and devices for the treatment of severe organ dysfunction (i.e., continuous renal replacement therapy equipment for acute kidney injury) could also be different. However, there has been no surveillance or any official report on the level of sepsis care provided by hospitals in Korea.

In this study, the age-sex-adjusted mortality rate was about 30%. This is consistent with the findings of previous population-based studies in which the mortality rate of 'severe sepsis' ranged from 26% to 40% \[[@b4-ceem-18-007],[@b6-ceem-18-007],[@b9-ceem-18-007],[@b15-ceem-18-007],[@b19-ceem-18-007],[@b30-ceem-18-007]-[@b32-ceem-18-007]\]. However, these are clearly higher than the 10% mortality rate used to define 'sepsis' in the Sepsis-3 definition paper \[[@b1-ceem-18-007]\]. This difference could be due to methodological differences in identifying organ dysfunctions. Organ dysfunctions in population-based studies are identified based-on diagnostic and intervention codes. Because only significant clinical/laboratory derangements would lead to any entry of related diagnostic codes or application of interventions, organ dysfunctions identified in population-based studies must be more severe.

Lastly, the association between ER presentation and increased mortality could be an important finding. More than half of the patients received their initial care in the ER and their outcomes were worse than the other patients. Currently, we do not know whether this is due to the severity of diseases among ER patients or the quality of care provided in the ERs. However, we believe that the ER should be regarded as a critical intervention point for sepsis care as the ward and ICU have been, because the initial treatment of more than half of sepsis cases would be initiated in the ER and there might be a lot of room for improvement.

The coding scheme used in this study is unique in several aspects. First, the coding system was based on the ICD-10 in contrast to previous studies that were based on the ICD-9. Second, we used a more comprehensive set of diseases for case definition. Third, we limited the cases that were treated with intravenous antibiotics. Fourth, we applied several new operational definitions for organ dysfunction as described in the [Appendix 1](#app1-ceem-18-007){ref-type="app"}.

This study has several limitations. First, this study was based on claim data in which the accuracy of diagnostic codes was limited and significant over- or under-coding could be present. Second, it was impossible to accurately know the timing of clinical events. Although the sequence of events based on the order of the fragmented claim records of each admission case was considered, the sequence of events within each claim record was not available. Third, the operational definition used to define sepsis cases was arbitrary and could lead to possible misclassifications. Lastly, the overall cost and mortality rate were all-cause estimates. Therefore, it should be considered that a significant proportion of them would be attributable to non-sepsis conditions.

Despite these limitations, this study, as other population-based studies using claim data, allowed for the examination of health care utilization and expenditure of sepsis in a real-world setting of Korea. For the first time, it estimated the overall burden of sepsis and the overall trend in the epidemiology of sepsis in Korea using nationally representative cohort data. It also identified risk factors for death in sepsis some of which may have implications for our health care delivery system.

In conclusion, sepsis is relatively common and is associated with a high mortality rate in Korea. Although the current national burden of sepsis is already high, it is expected to increase at a fast pace because of the ongoing population aging in Korea. Proactive measures to curtail this increase in societal burden should be sought and implemented.
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Supplementary Fig. 1 is available from: <https://doi.org/10.15441/ceem.18.007>.
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![Eight-year trend of sepsis incidence and mortality. (A) Crude and adjusted incidence rate of sepsis. (B) Relative change of incidence of sepsis according to the age group. (C) Relative change of incidence of sepsis according to the comorbidity. (D) Crude and adjusted 6-month mortality of sepsis. CCI, Charlson comorbidity index.](ceem-18-007f2){#f2-ceem-18-007}

![Eight-year trend of national expenditure on sepsis. (A) Mean cost per case of sepsis. (B) Total national cost of sepsis. KRW, Korean won.](ceem-18-007f3){#f3-ceem-18-007}

![Differential survival probability by age, comorbidity burden, organ dysfunction, and the site of infection. (A) Survival according to the age group. (B) Survival according to the comorbidity. (C) Survival according to the number of organ dysfunction. (D) Survival according to the site of infection. CCI, Charlson comorbidity index; MS, musculoskeletal.](ceem-18-007f4){#f4-ceem-18-007}

![Predictors of the 6-month mortality model of sepsis. CCI, Charlson comorbidity index; CNS, central nervous system; MS, musculoskeletal.](ceem-18-007f5){#f5-ceem-18-007}

![Predictive performance of the 6-month mortality model of sepsis. AUC, area under the receiver operating characteristic curve; CI, confidence interval.](ceem-18-007f6){#f6-ceem-18-007}

###### 

Patient characteristics of the study population

  Characteristics               2005                                              2006                  2007                  2008                  2009                  2010                  2011                  2012                  Total                 P-value             
  ----------------------------- ------------------------------------------------- --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- ------------------- ----------
  No. of cases/person-year      2,194/825,502                                     2,256/820,204         2,398/842,444         2,672/832,170         2,921/837,177         2,887/846,853         3,639/855,428         3,915/863,820         22,882/6,723,598                          
  Age group (yr)                                                                                                                                                                                                                                                  \<0.001             
                                15--64                                            972 (44.3)            978 (43.4)            957 (39.9)            1,084 (40.6)          1,172 (40.1)          1,089 (37.7)          1,307 (35.9)          1,295 (33.1)          8,854 (38.7)        
                                65--74                                            573 (26.1)            588 (26.1)            626 (26.1)            670 (25.1)            747 (25.6)            698 (24.2)            818 (22.5)            901 (23.0)            5,621 (24.6)        
                                75--84                                            499 (22.7)            522 (23.1)            614 (25.6)            658 (24.6)            726 (24.9)            793 (27.5)            1,037 (28.5)          1,207 (30.8)          6,056 (26.5)        
                                ≥ 85                                              150 (6.8)             168 (7.4)             201 (8.4)             260 (9.7)             276 (9.4)             307 (10.6)            477 (13.1)            512 (13.1)            2,351 (10.3)        
  Sex, male                     1,273 (58.0)                                      1,239 (54.9)          1,352 (56.4)          1,519 (56.8)          1,622 (55.5)          1,654 (57.3)          1,948 (53.5)          2,112 (53.9)          12,719 (55.6)         0.003               
  Comorbidities                                                                                                                                                                                                                                                                       
                                Chronic pulmonary disease                         473 (21.6)            500 (22.2)            505 (21.1)            585 (21.9)            636 (21.8)            600 (20.8)            723 (19.9)            811 (20.7)            4,833 (21.1)        0.384
                                Neoplasm                                          230 (10.5)            246 (10.9)            249 (10.4)            297 (11.1)            289 (9.9)             281 (9.7)             378 (10.4)            453 (11.6)            2,423 (10.6)        0.251
                                Chronic liver disease                             151 (6.9)             119 (5.3)             144 (6.0)             163 (6.1)             207 (7.1)             162 (5.6)             202 (5.6)             234 (6.0)             1,382 (6.0)         0.067
                                Renal disease                                     55 (2.5)              49 (2.2)              74 (3.1)              94 (3.5)              105 (3.6)             90 (3.1)              151 (4.1)             198 (5.1)             816 (3.6)           \< 0.001
                                Diabetes melitus                                  173 (7.9)             193 (8.6)             246 (10.3)            287 (10.7)            322 (11.0)            342 (11.8)            410 (11.3)            554 (14.2)            2,527 (11.0)        \< 0.001
                                Peripheral vascular disease                       31 (1.4)              30 (1.3)              34 (1.4)              40 (1.5)              46 (1.6)              57 (2.0)              62 (1.7)              89 (2.3)              389 (1.7)           0.051
                                Rheumatological disease                           8 (0.4)               24 (1.1)              12 (0.5)              16 (0.6)              16 (0.5)              28 (1.0)              22 (0.6)              32 (0.8)              158 (0.7)           0.036
  Charlson comorbidity index                                                                                                                                                                                                                                      \< 0.001            
                                0                                                 1,170 (53.3)          1,160 (51.4)          1,224 (51.0)          1,318 (49.3)          1,420 (48.6)          1,419 (49.2)          1,783 (49.0)          1,773 (45.3)          11,267 (49.2)       
                                1                                                 544 (24.8)            584 (25.9)            580 (24.2)            613 (22.9)            739 (25.3)            723 (25.0)            880 (24.2)            940 (24.0)            5,603 (24.5)        
                                2                                                 220 (10.0)            246 (10.9)            285 (11.9)            347 (13.0)            361 (12.4)            372 (12.9)            487 (13.4)            539 (13.8)            2,857 (12.5)        
                                \>2                                               260 (11.9)            266 (11.8)            309 (12.9)            394 (14.7)            401 (13.7)            373 (12.9)            489 (13.4)            663 (16.9)            3,155 (13.8)        
  Presented to emergency room   1,274 (58.1)                                      1,329 (58.9)          1,425 (59.4)          1,492 (55.8)          1,618 (55.4)          1,658 (57.4)          2,070 (56.9)          2,262 (57.8)          13,128 (57.4)         0.041               
  Medical department            1,520 (69.3)                                      1,560 (69.1)          1,686 (70.3)          1,884 (70.5)          2,059 (70.5)          2,018 (69.9)          2,630 (72.3)          2,855 (72.9)          16,212 (70.9)         0.007               
  Surgical department           668 (30.4)                                        694 (30.8)            708 (29.5)            782 (29.3)            855 (29.3)            865 (30.0)            1,002 (27.5)          1,053 (26.9)          6,627 (29.0)          0.006               
  Income level                                                                                                                                                                                                                                                    \< 0.001            
                                Lower                                             376 (17.1)            324 (14.4)            398 (16.6)            502 (18.8)            518 (17.7)            446 (15.4)            1,064 (29.2)          1,102 (28.1)          4,730 (20.7)        
                                Lower-middle                                      326 (14.9)            323 (14.3)            332 (13.8)            344 (12.9)            398 (13.6)            415 (14.4)            392 (10.8)            432 (11.0)            2,962 (12.9)        
                                Middle                                            372 (17.0)            387 (17.2)            422 (17.6)            492 (18.4)            509 (17.4)            490 (17.0)            496 (13.6)            472 (12.1)            3,640 (15.9)        
                                Upper-middle                                      475 (21.6)            490 (21.7)            516 (21.5)            533 (19.9)            594 (20.3)            547 (18.9)            619 (17.0)            670 (17.1)            4,444 (19.4)        
                                Upper                                             645 (29.4)            732 (32.4)            730 (30.4)            801 (30.0)            902 (30.9)            989 (34.3)            1,068 (29.3)          1,239 (31.6)          7,106 (31.1)        
  Hospital size (no. of beds)                                                                                                                                                                                                                                     \< 0.001            
                                \< 100                                            59 (2.7)              75 (3.3)              59 (2.5)              89 (3.3)              98 (3.4)              100 (3.5)             74 (2.0)              72 (1.8)              626 (2.7)           
                                100--299                                          399 (18.2)            417 (18.5)            451 (18.8)            531 (19.9)            580 (19.9)            650 (22.5)            808 (22.2)            801 (20.5)            4,637 (20.3)        
                                300--599                                          501 (22.8)            418 (18.5)            528 (22.0)            585 (21.9)            618 (21.2)            650 (22.5)            889 (24.4)            971 (24.8)            5,160 (22.6)        
                                600--999                                          645 (29.4)            668 (29.6)            739 (30.8)            779 (29.2)            856 (29.3)            813 (28.2)            1,002 (27.5)          1,136 (29.0)          6,638 (29.0)        
                                ≥ 1,000                                           590 (26.9)            678 (30.1)            621 (25.9)            688 (25.7)            769 (26.3)            674 (23.3)            866 (23.8)            935 (23.9)            5,821 (25.4)        
  Organ dysfunction                                                                                                                                                                                                                                                                   
                                Respiratory                                       1,163 (53.0)          1,172 (52.0)          1,286 (53.6)          1,400 (52.4)          1,482 (50.7)          1,459 (50.5)          1,851 (50.9)          2,041 (52.1)          11,854 (51.8)       0.218
                                Hemodynamic                                       1,024 (46.7)          1,075 (47.7)          1,160 (48.4)          1,251 (46.8)          1,393 (47.7)          1,359 (47.1)          1,731 (47.6)          1,799 (46.0)          10,792 (47.2)       0.679
                                Sepsis-induced cardiomyopathy                     5 (0.2)               7 (0.3)               11 (0.5)              10 (0.4)              20 (0.7)              18 (0.6)              25 (0.7)              46 (1.2)              142 (0.6)           \< 0.001
                                Hematologic                                       266 (12.1)            231 (10.2)            257 (10.7)            275 (10.3)            309 (10.6)            299 (10.4)            356 (9.8)             391 (10.0)            2,384 (10.4)        0.210
                                Renal                                             261 (11.9)            301 (13.3)            303 (12.6)            327 (12.2)            363 (12.4)            374 (13.0)            479 (13.2)            584 (14.9)            2,992 (13.1)        0.013
                                Hepatic                                           198 (9.0)             167 (7.4)             176 (7.3)             230 (8.6)             206 (7.1)             188 (6.5)             194 (5.3)             159 (4.1)             1,518 (6.6)         \< 0.001
                                Metabolic                                         29 (1.3)              27 (1.2)              37 (1.5)              39 (1.5)              33 (1.1)              37 (1.3)              61 (1.7)              65 (1.7)              328 (1.4)           0.469
                                Neurologic                                        115 (5.2)             121 (5.4)             130 (5.4)             179 (6.7)             180 (6.2)             182 (6.3)             275 (7.6)             331 (8.5)             1,513 (6.6)         \< 0.001
  No. of organ dysfunctions                                                                                                                                                                                                                                       0.351               
                                1                                                 1,585 (72.2)          1,651 (73.2)          1,701 (70.9)          1,962 (73.4)          2,138 (73.2)          2,147 (74.4)          2,670 (73.4)          2,846 (72.7)          16,700 (73.0)       
                                2                                                 420 (19.1)            423 (18.8)            495 (20.6)            481 (18.0)            559 (19.1)            519 (18.0)            699 (19.2)            747 (19.1)            4,343 (19.0)        
                                3                                                 134 (6.1)             132 (5.9)             152 (6.3)             152 (5.7)             173 (5.9)             163 (5.6)             193 (5.3)             229 (5.8)             1,328 (5.8)         
                                ≥4                                                55 (2.5)              50 (2.2)              50 (2.1)              77 (2.9)              51 (1.7)              58 (2.0)              77 (2.1)              93 (2.4)              511 (2.2)           
  Site of infection                                                                                                                                                                                                                                               0.001               
                                Respiratory                                       1,122 (51.1)          1,189 (52.7)          1,307 (54.5)          1,431 (53.6)          1,529 (52.3)          1,559 (54.0)          1,951 (53.6)          2,167 (55.4)          12,255 (53.6)       
                                CNS                                               14 (0.6)              19 (0.8)              20 (0.8)              12 (0.4)              18 (0.6)              30 (1.0)              18 (0.5)              19 (0.5)              150 (0.7)           
                                Gastrointestinal                                  444 (20.2)            445 (19.7)            441 (18.4)            508 (19.0)            570 (19.5)            541 (18.7)            714 (19.6)            720 (18.4)            4,383 (19.2)        
                                Genitourinary                                     122 (5.6)             147 (6.5)             183 (7.6)             188 (7.0)             202 (6.9)             218 (7.6)             259 (7.1)             310 (7.9)             1,629 (7.1)         
                                Musculoskeletal, skin and soft tissue 114 (5.2)                         87 (3.9)              99 (4.1)              130 (4.9)             154 (5.3)             146 (5.1)             164 (4.5)             174 (4.4)             1,068 (4.7)         
                                Endocarditis                                      5 (0.2)               7 (0.3)               4 (0.2)               9 (0.3)               8 (0.3)               8 (0.3)               11 (0.3)              11 (0.3)              63 (0.3)            
                                Device-related                                    16 (0.7)              5 (0.2)               9 (0.4)               14 (0.5)              12 (0.4)              7 (0.2)               15 (0.4)              24 (0.6)              102 (0.4)           
                                Unspecified                                       357 (16.3)            357 (15.8)            335 (14.0)            380 (14.2)            428 (14.7)            378 (13.1)            507 (13.9)            490 (12.5)            3,232 (14.1)        
  Septic shock                  1,014 (46.2)                                      1,063 (47.1)          1,146 (47.8)          1,227 (45.9)          1,367 (46.8)          1,320 (45.7)          1,694 (46.6)          1,739 (44.4)          10,570 (46.2)         0.242               
  Length of stay                                                                                                                                                                                                                                                                      
                                Median (IQR)                                      12.0 (7.0-24.0)       13.0 (7.0-26.0)       14.0 (7.0-26.0)       13.0 (7.0-27.0)       12.0 (7.0-25.0)       13.0 (7.0-26.0)       13.0 (7.0-28.0)       14.0 (7.0-29.0)       13.0 (7.0-26.0)     \< 0.001
                                Mean ± SD                                         24.7 ± 44.5           27.0 ± 48.3           26.6 ± 43.1           27.3 ± 48.8           25.6 ± 47.2           29.2 ± 55.4           32.5 ± 62.3           36.3 ± 69.7           29.3 ± 55.0         
  Cost (10,000 KRW)                                                                                                                                                                                                                                                                   
                                Median (IQR)                                      209.8 (113.9-449.5)   240.5 (131.1-539.8)   283.5 (144.8-604.8)   263.8 (140.6-633.2)   264.8 (144.3-617.5)   292.6 (151.2-645.9)   306.3 (158.0-675.1)   309.9 (163.1-731.5)   276 (144.2-621.8)   \< 0.001
                                Mean ± SD                                         425.3 ± 628.1         513.9 ± 804.3         548.6 ± 801.2         574.2 ± 959.5         593.9 ± 951.3         620.2 ± 1,002.5       681.2 ± 1,079.9       743.3 ± 1,226.6       605.6 ± 984.8       
  ICU admission                 747 (34.0)                                        722 (32.0)            806 (33.6)            792 (29.6)            896 (30.7)            821 (28.4)            1,139 (31.3)          1,208 (30.9)          7,131 (31.2)          \< 0.001            
  6-month mortality             582 (26.5)                                        628 (27.8)            696 (29.0)            790 (29.6)            831 (28.4)            881 (30.5)            1,089 (29.9)          1,243 (31.7)          6,740 (29.5)          0.001               

Values are presented as number (%) unless otherwise indicated.

CNS, central nervous system; IQR, interquartile range; SD, standard deviation; KRW, Korean won; ICU, intensive care unit.

###### 

Multivariable logistic regression model for 6-month mortality

  Characteristics                         OR                                    95% CI       P-value       
  --------------------------------------- ------------------------------------- ------------ ------------- ----------
  Year                                    2006 (vs. 2005)                       1.10         0.94--1.29    0.234
                                          2007                                  1.04         0.89--1.22    0.589
                                          2008                                  1.05         0.90--1.22    0.511
                                          2009                                  1.01         0.87--1.18    0.851
                                          2010                                  1.10         0.95--1.28    0.208
                                          2011                                  0.97         0.84--1.11    0.631
                                          2012                                  1.00         0.87--1.15    0.998
  Age (yr)                                65--74 (vs. \<65)                     1.95         1.77--2.15    \< 0.001
                                          75--84                                3.68         3.34--4.05    \< 0.001
                                          ≥ 85                                  9.25         8.18--10.45   \< 0.001
  Sex, female                             0.70                                  0.66--0.76   \< 0.001      
  Charlson comorbidity index              1 (vs. 0)                             1.08         0.98--1.18    0.104
                                          2 (vs. 0)                             2.39         2.16--2.65    \< 0.001
                                          \> 2 (vs. 0)                          4.22         3.81--4.66    \< 0.001
  ER visit (vs. all other presentation)   1.12                                  1.03--1.21   0.005         
  Medical departments (vs. all others)    2.09                                  1.89--2.31   \< 0.001      
  Income level                            Lower-middle (vs. lower)              1.04         0.92--1.17    0.563
                                          Middle                                1.01         0.90--1.13    0.904
                                          Upper-middle                          0.92         0.82--1.02    0.115
                                          Upper                                 0.85         0.77--0.94    0.001
  Hospital size (beds)                    100--299 (vs. \<100)                  1.12         0.89--1.42    0.329
                                          300--599                              0.75         0.59--0.96    0.019
                                          600--999                              0.55         0.43--0.69    \< 0.001
                                          ≥ 1,000                               0.51         0.40--0.65    \< 0.001
  No. of organ dysfunctions               2 (vs. 1)                             2.90         2.65--3.17    \< 0.001
                                          3                                     6.30         5.45--7.28    \< 0.001
                                          ≥4                                    10.28        8.18--12.91   \< 0.001
  Site of infection                       CNS (vs. respiratory)                 1.69         1.12--2.55    0.012
                                          Gastrointestinal                      0.69         0.62--0.77    \< 0.001
                                          Genitourinary                         0.48         0.41--0.57    \< 0.001
                                          Musculoskeletal, skin & soft tissue   0.47         0.37--0.60    \< 0.001
                                          Endocarditis                          0.93         0.48--1.79    0.829
                                          Device-related                        0.19         0.07--0.47    \< 0.001
                                          Unspecified                           1.30         1.17--1.46    \< 0.001
  Septic shock (vs. no septic shock)      1.79                                  1.64--1.95   \< 0.001      

OR, odds ratio; CI, confidence interval; ER, emergency room; CNS, central nervous system.

###### 

Parsimonious multivariable logistic regression model derived from training set

  Characteristics                        OR                                    95% CI       P-value       
  -------------------------------------- ------------------------------------- ------------ ------------- ----------
  Age (yr)                               65--74 (vs. \<65)                     1.91         1.71--2.12    \< 0.001
                                         75--84                                3.63         3.27--4.02    \< 0.001
                                         ≥ 85                                  9.16         8.01--10.48   \< 0.001
  Sex, female                            0.70                                  0.64--0.76   \< 0.001      
  Charlson comorbidity index             1 (vs. 0)                             1.10         1.00--1.21    0.058
                                         2 (vs. 0)                             2.33         2.08--2.62    \< 0.001
                                         \> 2 (vs. 0)                          3.98         3.56--4.45    \< 0.001
  Medical departments (vs. all others)   2.12                                  1.90--2.37   \< 0.001      
  Hospital size (beds)                   100--299 (vs. \<100)                  1.28         0.98--1.66    0.070
                                         300--599                              0.88         0.68--1.15    0.346
                                         600--999                              0.66         0.51--0.86    0.002
                                         ≥ 1,000                               0.60         0.46--0.79    \< 0.001
  No. of organ dysfunctions              2 (vs. 1)                             2.87         2.60--3.17    \< 0.001
                                         3                                     6.17         5.27--7.23    \< 0.001
                                         ≥4                                    11.28        8.73--14.58   \< 0.001
  Site of infection                      CNS (vs. respiratory)                 1.89         1.20--2.98    0.006
                                         Gastrointestinal                      0.70         0.62--0.78    \< 0.001
                                         Genitourinary                         0.50         0.41--0.60    \< 0.001
                                         Musculoskeletal, skin & soft tissue   0.44         0.34--0.58    \< 0.001
                                         Endocarditis                          0.95         0.46--1.95    0.884
                                         Device-related                        0.23         0.09--0.59    0.002
                                         Unspecified                           1.30         1.15--1.47    \< 0.001
  Septic shock (vs. no septic shock)     1.79                                  1.63--1.97   \< 0.001      

OR, odds ratio; CI, confidence interval; CNS, central nervous system.
